期刊
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
卷 29, 期 9, 页码 964-973出版社
WILEY
DOI: 10.1002/jhbp.1164
关键词
creatinine; cystatin C; hepatocellular carcinoma; prognosis
资金
- [JP17K09225]
The ratio of creatinine and cystatin C estimated glomerular filtration rates (eGFRcre/eGFRcys) is positively correlated with sarcopenia. This study investigated the relationship between eGFRcre/eGFRcys and long-term prognosis in patients after hepatic resection for hepatocellular carcinoma (HCC). The results showed that eGFRcre/eGFRcys can predict overall and recurrence-free survival in HCC patients undergoing hepatic resection.
Background The ratio of creatinine and cystatin C estimated glomerular filtration rates (eGFRcre/eGFRcys) is significantly positively correlated with sarcopenia. However, there are no published reports on the relationship between eGFRcre/eGFRcys and long-term prognosis in patients after hepatic resection for hepatocellular carcinoma (HCC). Methods A total of 157 patients who had undergone curative hepatic resection for HCC were retrospectively reviewed. Cystatin C levels were measured in serum samples that had been frozen after collection at surgery. We aimed to investigate the significance of cystatin C in prognostic value following hepatic resection for HCC. Results The best cut-off eGFRcre/eGFRcys value for overall survival after hepatic resection for HCC was 1.0025. High eGFRcre/eGFRcys was significantly associated with poor liver function, low skeletal muscle mass, large tumor size, large ascitic volume, worse overall and recurrence-free survival. The eGFRcre/eGFRcys was significantly related to severe recurrence patterns (multiple liver recurrences, distant metastasis). Conclusions Preoperative eGFRcre/eGFRcys can predict overall and recurrence-free survival in HCC patients undergoing hepatic resection. The eGFRcre/eGFRcys is a simple and reliable surrogate marker that indicates eligibility for hepatic resection for HCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据